Expression of prognostic factors (EGFR, ER) by immunohistochemical staining method in male breast cancer.

Hyuncheol Chung, D. L. Kim, E. H. Koh, J. H. Kim, J. K. Roh, J. S. Min, K. S. Lee, W. I. Yang, B. S. Kim, K. B. Lee

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Twelve male patients with operable breast cancer were evaluated for the expression of prognostic factors by immunohistochemical staining assay. Seven patients were stage I & II, and five patients were stage III. Axillary lymph node positivity was 42%. Nine patients were nuclear grade I, three were nuclear grade II, and none were nuclear grade III. The expression rate of EGFR (epidermal growth factor receptor), ER (estrogen receptor) were 8.3%, 70.0% respectively. This limited data suggest better tumor behavior in male than in female breast cancer. Adjuvant treatment should be considered in male breast cancer just as in females, based on axillary lymph node and ER states.

Original languageEnglish
Pages (from-to)126-130
Number of pages5
JournalYonsei medical journal
Volume32
Issue number2
DOIs
Publication statusPublished - 1991 Jan 1

Fingerprint

Male Breast Neoplasms
Epidermal Growth Factor Receptor
Staining and Labeling
Lymph Nodes
Breast Neoplasms
Estrogen Receptors
Neoplasms

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Chung, Hyuncheol ; Kim, D. L. ; Koh, E. H. ; Kim, J. H. ; Roh, J. K. ; Min, J. S. ; Lee, K. S. ; Yang, W. I. ; Kim, B. S. ; Lee, K. B. / Expression of prognostic factors (EGFR, ER) by immunohistochemical staining method in male breast cancer. In: Yonsei medical journal. 1991 ; Vol. 32, No. 2. pp. 126-130.
@article{9236422cdf824f06b64c8878be10475c,
title = "Expression of prognostic factors (EGFR, ER) by immunohistochemical staining method in male breast cancer.",
abstract = "Twelve male patients with operable breast cancer were evaluated for the expression of prognostic factors by immunohistochemical staining assay. Seven patients were stage I & II, and five patients were stage III. Axillary lymph node positivity was 42{\%}. Nine patients were nuclear grade I, three were nuclear grade II, and none were nuclear grade III. The expression rate of EGFR (epidermal growth factor receptor), ER (estrogen receptor) were 8.3{\%}, 70.0{\%} respectively. This limited data suggest better tumor behavior in male than in female breast cancer. Adjuvant treatment should be considered in male breast cancer just as in females, based on axillary lymph node and ER states.",
author = "Hyuncheol Chung and Kim, {D. L.} and Koh, {E. H.} and Kim, {J. H.} and Roh, {J. K.} and Min, {J. S.} and Lee, {K. S.} and Yang, {W. I.} and Kim, {B. S.} and Lee, {K. B.}",
year = "1991",
month = "1",
day = "1",
doi = "10.3349/ymj.1991.32.2.126",
language = "English",
volume = "32",
pages = "126--130",
journal = "Yonsei Medical Journal",
issn = "0513-5796",
publisher = "Yonsei University College of Medicine",
number = "2",

}

Chung, H, Kim, DL, Koh, EH, Kim, JH, Roh, JK, Min, JS, Lee, KS, Yang, WI, Kim, BS & Lee, KB 1991, 'Expression of prognostic factors (EGFR, ER) by immunohistochemical staining method in male breast cancer.', Yonsei medical journal, vol. 32, no. 2, pp. 126-130. https://doi.org/10.3349/ymj.1991.32.2.126

Expression of prognostic factors (EGFR, ER) by immunohistochemical staining method in male breast cancer. / Chung, Hyuncheol; Kim, D. L.; Koh, E. H.; Kim, J. H.; Roh, J. K.; Min, J. S.; Lee, K. S.; Yang, W. I.; Kim, B. S.; Lee, K. B.

In: Yonsei medical journal, Vol. 32, No. 2, 01.01.1991, p. 126-130.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Expression of prognostic factors (EGFR, ER) by immunohistochemical staining method in male breast cancer.

AU - Chung, Hyuncheol

AU - Kim, D. L.

AU - Koh, E. H.

AU - Kim, J. H.

AU - Roh, J. K.

AU - Min, J. S.

AU - Lee, K. S.

AU - Yang, W. I.

AU - Kim, B. S.

AU - Lee, K. B.

PY - 1991/1/1

Y1 - 1991/1/1

N2 - Twelve male patients with operable breast cancer were evaluated for the expression of prognostic factors by immunohistochemical staining assay. Seven patients were stage I & II, and five patients were stage III. Axillary lymph node positivity was 42%. Nine patients were nuclear grade I, three were nuclear grade II, and none were nuclear grade III. The expression rate of EGFR (epidermal growth factor receptor), ER (estrogen receptor) were 8.3%, 70.0% respectively. This limited data suggest better tumor behavior in male than in female breast cancer. Adjuvant treatment should be considered in male breast cancer just as in females, based on axillary lymph node and ER states.

AB - Twelve male patients with operable breast cancer were evaluated for the expression of prognostic factors by immunohistochemical staining assay. Seven patients were stage I & II, and five patients were stage III. Axillary lymph node positivity was 42%. Nine patients were nuclear grade I, three were nuclear grade II, and none were nuclear grade III. The expression rate of EGFR (epidermal growth factor receptor), ER (estrogen receptor) were 8.3%, 70.0% respectively. This limited data suggest better tumor behavior in male than in female breast cancer. Adjuvant treatment should be considered in male breast cancer just as in females, based on axillary lymph node and ER states.

UR - http://www.scopus.com/inward/record.url?scp=0026177906&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026177906&partnerID=8YFLogxK

U2 - 10.3349/ymj.1991.32.2.126

DO - 10.3349/ymj.1991.32.2.126

M3 - Article

C2 - 1949915

AN - SCOPUS:0026177906

VL - 32

SP - 126

EP - 130

JO - Yonsei Medical Journal

JF - Yonsei Medical Journal

SN - 0513-5796

IS - 2

ER -